Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Intrasense Board/Management Information 2018

Feb 9, 2018

1447_iss_2018-02-09_effad2ef-5321-4e4d-b3d9-2943662d6695.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Press Release

Montpellier (France), February 9, 2018, 8:00 am CET

Governancechanges atIntrasense

Intrasense (FR001117179886 - ALINS), a specialist in medical imaging software solutions, today announces the appointment of a new management team, with a new Chairman and new Chief Executive Officer.

In order to develop Intrasense business and enable it to achieve operational profitability as quickly as possible, the Board of Directors, which met on February 8, 2018, appointed Nicolas Michelon Chairman of the Board of Directors and Nicolas Reymond Chief Executive Officer.

The Board of Directors would like to thank Stéphane Chemouny for the work accomplished during his term as Chairman and Chief Executive Officer, which ends today.

Nicolas Reymond, 36 years old, formerly Director of Business Development and Partnerships of Intrasense, brings his diverse experience of the medical software industry. Graduate from National Polytechnic Institute of Toulouse (MSc in engineering), Nicolas previously spent 10 years at Philips Healthcare, holding various positions and responsibilities within R&D, Operations, Marketing and Business Development, both in France and abroad.

About Intrasense

Founded in 2004, Intrasense develops and markets a unique medical device called Myrian®, a software platform that facilitates diagnosis, decision-making and therapeutic follow-up and makes them more secure. Thanks to Myrian®, more than 800 health institutions spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner…). Enriched with expert clinical modules dedicated to specific pathologies, Myrian® also provides a universal image treatment solution that can be fully integrated in any health information system. Intrasense includes 45 employees among which 20 are dedicated to Research & Development. Intrasense has been labelled 'innovative company' by the BPI and invested more than 10 million euros in Research & Development since its creation.

Further information, visit www.intrasense.fr.

Contacts

Intrasense

Nicolas Reymond Chief Executive Officer

Christophe Lamboeuf Chief Financial Officer Tél. : +33 4 67 130 130 [email protected]

NewCap

Investor communication

Valentine Brouchot Pierre Laurent Tél. : +33 1 44 71 94 96 [email protected]